2 October 2014

Richard White completes the British Heart Foundation's Oxford to Cambridge bike ride!

RichardBlessed with near-perfect weather conditions for cycling (dry and warm, with very little wind), Oxford PharmaGenesis Commercial Director, Richard White, completed the British Heart Foundation’s Oxford to Cambridge bike ride in a time of 5 hours and 45 minutes on Saturday 27 September.

“This was a superbly organized event and I felt very proud to be one of hundreds of people of all ages riding across the country in support of such a worthy cause,” said Richard. “I have really been touched by the donations that I have received, and am hugely grateful to everyone who has sponsored me – thank you to everyone for your generosity!”

If you would still like to make a donation (now that the task has been completed), please visit Richard’s JustGiving page at https://www.justgiving.com/richyrichwhite/.

 

26 September 2014

The challenge of irritable bowel syndrome in primary care

Pali Hugin
Professor Pali Hungin

Primary care physicians use a range of approaches to manage irritable bowel syndrome (IBS) in primary care, reports a systematic review co-authored by the Rome Foundation and researchers from Oxford PharmaGenesis. The article, which appeared online in Alimentary Pharmacology & Therapeutics this month, shows that primary care physicians are often comfortable diagnosing and managing IBS without specialist diagnostic tests or referral to a gastroenterologist. Continue reading

24 September 2014

Scientists flock to London career event

On Friday 19 September 2014 a bunch of friendly Oxford PharmaGenesis faces made the journey to London to attend The Naturejobs Career Expo 2014, which was held at the Business Design Centre. It was a very successful event and the team met some fantastic candidates. Continue reading

18 September 2014

Exclusive Interview with Dr Jonathan Morton, Oxford PharmaGenesis Ltd, Speaking at The World Orphan Drug Congress

Jon Morton
Dr Jonathan Morton (Communications Director, Rare and Orphan Diseases Practice at Oxford PharmaGenesis Ltd)

Dr Jonathan Morton, Communications Director of our Rare and Orphan Diseases Practice, will be speaking at the World Orphan Drug Congress in November. In the interview below, he provides an insight into the upcoming panel discussion at this congress, as well what he hopes to achieve in order to improve standards of care for patients with rare and orphan diseases. Dr Morton’s panel, “A problem shared … how can multi-stakeholder collaboration facilitate patient access initiatives?”, will include participants from the MPS Society, PPi Ltd and PTC Therapeutics. Continue reading

12 September 2014

Richard White cycles from Oxford to Cambridge for the British Heart Foundation

4Following on from his ALS Ice Bucket Challenge, Oxford PharmaGenesis Commercial Director Dr Richard White will be taking part in the Oxford to Cambridge bike ride on Saturday 27 September to raise money for the British Heart Foundation.

“Unfortunately, cardiovascular disease runs in my family,” said Richard, who took up road cycling last year in order to keep fit. “It is a terrible thing, as much when it brings life to a sudden end (as happened to my Aunty Betty and my Uncle Doug) as when it leads to incapacitation of previously active and healthy people (my grandmother). Pharmaceutical companies and public health initiatives have made amazing progress in reducing the incidence of heart attack and stroke. Continue reading

8 September 2014

Richard White and Jonathan Morton on the rocks … in a different way!

If anyone has any connection with the world of social media, they will be aware of the viral craze going around … the #icebucketchallenge in aid of the Amyotrophic Lateral Sclerosis Association.

Continue reading

1 24 25 26 27 28